THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Drug firms lagging on openness

Despite vow, few studies publicized

By Christopher Rowland
Globe Staff / January 9, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Six months after the drug industry vowed to make its clinical trials more transparent, and three months after launching a common website to give the public ''unprecedented access" to studies both good and bad, drug companies have posted unpublished trial results on the site for just five drugs. (Full article: 1656 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass